biontech

BioNTech Takes Aim at Keytruda With Up to $950M Biotheus Buy

BioSpace - 13 Nov 2024
BioNTech Takes Aim at Keytruda With Up to $950M Biotheus Buy  ...

• More

BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition

Yahoo Finance - 13 Nov 2024
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition  ...

• More

BioNTech Stock Got A IBD RS Rating Lift

Investor's Business Daily - 14 Nov 2024
BioNTech Stock Got A IBD RS Rating Lift  ...

• More

BioNTech Rings the Opening Bell

Nasdaq - 14 Nov 2024
BioNTech Rings the Opening Bell  ...

• More

BioNTech signs agreement to acquire Biotheus

Pharmaceutical Technology - 14 Nov 2024
BioNTech signs agreement to acquire Biotheus  ...

• More

BioNTech oncology acquisition to advance bispecific antibodies

European Pharmaceutical Review - 14 Nov 2024
BioNTech oncology acquisition to advance bispecific antibodies  ...

• More

The Analyst Landscape: 17 Takes On BioNTech

Benzinga - 14 Nov 2024
The Analyst Landscape: 17 Takes On BioNTech  ...

• More

BioNTech SE’s Strategic Growth in Oncology and mRNA

TipRanks - 14 Nov 2024
BioNTech SE’s Strategic Growth in Oncology and mRNA  ...

• More

Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17

News-Medical.Net - 12 Nov 2024
Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17  ...

• More

Comparing the COVID-19 Vaccines: How Are They Different?

Yale Medicine - 25 Oct 2024
Comparing the COVID-19 Vaccines: How Are They Different?  ...

• More

BioNTech to acquire Chinese cancer drugmaker Biotheus for $800m

World Pharmaceutical Frontiers - 14 Nov 2024
BioNTech to acquire Chinese cancer drugmaker Biotheus for $800m  ...

• More

Germany’s BioNTech buys Biotheus in US$800 million push into cancer drugs

South China Morning Post - 14 Nov 2024
Germany’s BioNTech buys Biotheus in US$800 million push into cancer drugs  ...

• More

BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition

Benzinga - 13 Nov 2024
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition  ...

• More

BioNTech to Report Q3 Earnings: Is a Beat in the Cards?

Yahoo Finance - 25 Oct 2024
BioNTech to Report Q3 Earnings: Is a Beat in the Cards?  ...

• More

BioNTech to Acquire Biotheus in $950 Million Deal

MarketWatch - 13 Nov 2024
BioNTech to Acquire Biotheus in $950 Million Deal  ...

• More

BioNTech's $950M Biotheus Acquisition Expands Cancer Drug Pipeline, China Presence | BNTX Stock News

StockTitan - 13 Nov 2024
BioNTech's $950M Biotheus Acquisition Expands Cancer Drug Pipeline, China Presence | BNTX Stock News  ...

• More

BioNTech buys Biotheus and its Keytruda rival for $950m

pharmaphorum - 13 Nov 2024
BioNTech buys Biotheus and its Keytruda rival for $950m  ...

• More

BioNTech Acquires Biotheus to Enhance Cancer Therapies

TipRanks - 13 Nov 2024
BioNTech Acquires Biotheus to Enhance Cancer Therapies  ...

• More

BioNTech-OncoC4 phase 3 cancer trial under partial hold after varying results reported

Fierce Biotech - 18 Oct 2024
BioNTech-OncoC4 phase 3 cancer trial under partial hold after varying results reported  ...

• More